varegacestat

DRUG4 trials

Sponsors

Immunome, Inc.

Conditions

Healthy VolunteerHepatic Impairment (HI)

Phase 1

A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

CompletedNCT06677996

Immunome, Inc.Healthy Volunteer

Start: 2024-11-11End: 2025-05-07Updated: 2025-05-11

A Varegacestat Hepatic Impairment Study

CompletedNCT06841315

Immunome, Inc.Healthy Volunteer, Hepatic Impairment (HI)

Start: 2025-03-07End: 2026-03-06Updated: 2026-03-10

A Phase 1 Mass Balance Study of Varegacestat

CompletedNCT06845852

Immunome, Inc.Healthy Volunteer

Start: 2025-02-25End: 2025-03-26Updated: 2025-09-26

A Cardiac Liability Study of Varegacestat in Healthy Participants

CompletedNCT06855264

Immunome, Inc.Healthy Volunteer

Start: 2025-02-24End: 2025-05-06Updated: 2025-09-24